Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

Launched by INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC, UNIVERSITY LAVAL · Dec 11, 2023

Keywords

ClinConnect Summary

The RE-DRT Study is a clinical trial that aims to better understand a specific problem that can happen after a medical procedure called Left Atrial Appendage Occlusion (LAAO). This procedure is used to reduce the risk of stroke in patients with certain heart conditions. However, some patients may develop what is known as device-related thrombus (DRT), which is a blood clot that forms on the device used during the procedure. This study will look at how often DRT occurs, what factors might contribute to it, and the potential risks involved, such as stroke or other serious health issues.

To be eligible for this trial, participants must be at least 18 years old and have been diagnosed with DRT after LAAO, as seen through specific imaging tests like transesophageal echocardiography (TEE) or cardiac CT scans. The study is not yet recruiting participants, but it will provide important insights into how best to monitor and manage DRT after LAAO. Those who take part in the trial can expect to undergo evaluations and imaging to track their condition over time, helping researchers gather valuable information to improve patient care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with diagnosis of probable/definite DRT after LAAO detected by transesophageal echocardiography (TEE) or cardiac computed tomography (CT).
• • Age≥18 years old.
• Exclusion Criteria:
• • Unable to provide informed consent